These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study. DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552 [TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone use in ventilated extremely preterm infants decreased bronchopulmonary dysplasia with no effects on neurodevelopment after two years. Renault A; Patkaï J; Dassieu G; El Ayoubi M; Canouï-Poitrine F; Durrmeyer X Acta Paediatr; 2016 Sep; 105(9):1047-55. PubMed ID: 27239054 [TBL] [Abstract][Full Text] [Related]
4. Corticosteroids for the treatment and prevention of bronchopulmonary dysplasia. Soll RF Neonatology; 2010; 98(2):109-10. PubMed ID: 20150749 [No Abstract] [Full Text] [Related]
5. Trial of early neonatal hydrocortisone: two-year follow-up. Peltoniemi OM; Lano A; Puosi R; Yliherva A; Bonsante F; Kari MA; Hallman M; Neonatology; 2009; 95(3):240-7. PubMed ID: 18931525 [TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids and children. Baraldi E; Filippone M N Engl J Med; 2006 Aug; 355(6):625; author reply 625-6. PubMed ID: 16903019 [No Abstract] [Full Text] [Related]
7. Early closure of the Watterberg trial. Roberts RS Pediatrics; 2004 Dec; 114(6):1670-1. PubMed ID: 15574631 [No Abstract] [Full Text] [Related]
8. Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia? Eichenwald EC; Stark AR Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F334-7. PubMed ID: 17712183 [TBL] [Abstract][Full Text] [Related]
9. [Corticosteroid therapy for the prophylaxis of bronchopulmonary dysplasia in kids with very low body weight]. Tsvetkova S; Chernookova V Akush Ginekol (Sofiia); 2002; 41 Suppl 2():21-3. PubMed ID: 19708190 [No Abstract] [Full Text] [Related]
11. Weighing statistical certainty against ethical, clinical, and biologic expediency: the contributions of the Watterberg trial tip the scales in the right direction. Gordon PV Pediatrics; 2005 May; 115(5):1446-7; author reply 1447. PubMed ID: 15867074 [No Abstract] [Full Text] [Related]
12. Postnatal steroids and neurodevelopmental outcomes: a problem in the making. Barrington KJ Pediatrics; 2001 Jun; 107(6):1425-6. PubMed ID: 11389269 [No Abstract] [Full Text] [Related]
13. Postnatal steroids for bronchopulmonary dysplasia: where are we now? Watterberg KL J Pediatr; 2007 Apr; 150(4):327-8. PubMed ID: 17382102 [No Abstract] [Full Text] [Related]
14. [Corticotherapy: too dangerous a treatment for bronchopulmonary dysplasia?]. Walti H; Moriette G; de Ajuriaguerra M; de Gamarra E; Relier JP Ann Pediatr (Paris); 1986 Jan; 33(1):29-32. PubMed ID: 3963699 [No Abstract] [Full Text] [Related]
15. Which course of dexamethasone? Bloomfield FH; Knight DB; Harding JE Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F80. PubMed ID: 10325825 [No Abstract] [Full Text] [Related]
17. [Glucocorticoid therapy in childhood]. Butenandt O Fortschr Med; 1991 Aug; 109(23):455-9. PubMed ID: 1916578 [TBL] [Abstract][Full Text] [Related]
18. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants. Yoder BA; Harrison M; Clark RH Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192 [TBL] [Abstract][Full Text] [Related]
20. Systemic Corticosteroids for the Prevention of Bronchopulmonary Dysplasia: Picking the Right Drug for the Right Baby. Rostas SE; McPherson C Neonatal Netw; 2016; 35(4):234-9. PubMed ID: 27461202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]